Most coronaviruses, including those causing the common cold, are not associated with significant mortality. The novel SARS-Coronavirus-2 (SARS-CoV-2) identified in 2019 causes a collection of symptoms that can cause severe illness, which has become known as COVID-19. The SARS-CoV-2 virus is contagious1 and infected persons can be asymptomatic2 or exhibit symptoms ranging from mild to severe. Symptoms include fever; chills; cough; shortness of breath/difficulty breathing; fatigue; muscle, joint or body aches; rash; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting and diarrhea.3
Complications of SARS-CoV-2 include pneumonia, acute respiratory failure, Acute, Respiratory Distress Syndrome (ARDS), acute kidney, liver, and heart injury, septic shock, disseminated intravascular coagulation (DIC), rhabdomyolysis (muscle breakdown), chronic fatigue syndrome, blood clots and death. Many complications may be caused by a condition known as a cytokine storm.4 Click to learn more about SARS-CoV-2 virus…
New ways to make vaccines including new technologies and production platforms, such as mRNA vaccines, have become favored over the older traditional ways to make vaccines in the COVID-19 vaccine race.5 6 Nearly 300 different types of COVID-19 vaccines are being developed worldwide.7 Currently, three experimental COVID-19 vaccines have been granted an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA) for distribution and use in the U.S.8 9 10 Several more experimental COVID-19 vaccines are expected to be given EUA status in 2021.11 12
U.S. Emergency Use Authorization does not mean that the FDA has evaluated all safety and efficacy data and officially approved licensure of the vaccine. Instead, the EUA status allows vaccine manufacturers to release an experimental vaccine for voluntary use and requires that vaccine recipients must “have the option to accept or refuse the vaccine.”13 NVIC encourages consumers to make informed vaccination decisions and to read the FDA fact sheet and other information and resources provided on our website. Click to learn more about COVID-19 vaccines…
NVIC encourages you to become fully informed about SARS-CoV-2 virus and the COVID-19 vaccine by reading all sections in the Table of Contents below, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.
IMPORTANT NOTE: NVIC encourages you to become fully informed about covid-19 and the covid-19 vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.
Updated July 22, 2021
2 Rivett L, Sridhar S, Sparkes D, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. ELife 2020; 9:e58728.
10 U.S. Food and Drug Administration. FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine. Feb. 27, 2021.
11 Knapp A, Rosenbaum L. Here’s What You Need to Know About Astra Zeneca’s COVID-19 Vaccine. Forbes Nov. 23 2020.
12 Robert-Guroff M. Replicating and non-replicating viral vectors for vaccine development. Curr Opin Biotechnol. December 2007;18(6):546-556.
13 U.S. Food and Drug Administration. Emergency Use Authorization for Vaccines Explained. Nov. 20, 2020.
18 Fisher BL. Coronavirus (COVID-19) Pandemic: NVIC Special Report. National Vaccine Information Center (NVIC) February-June 2020.
20 Garg S, Kim L, Whitaker M, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020. Morbidity and Mortality Weekly Report 2020; 69(15): 458-464.
24 Levine H. The 5 Stages of COVID-19 Vaccine Development: What You Need to Know About How a Clinical Trial Works. Johnson & Johnson Sept. 23, 2020.
25 Weintraub A. J&J COVID-19 vaccine candidate protects monkeys after single dose. Fierce Biotech July 30, 2020.
26 U.S. Food and Drug Administration. FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine. Press Release Feb. 27, 2021.
27 Sky News Australia. WHO doesn’t have evidence vaccines prevent people transmitting virus to others. You Tube Dec. 28, 2020.
28 Kim S. Dr. Fauci on Mandatory COVID Vaccines: ‘Everything Will Be on the Table. Newsweek Jan. 1, 2021.
29 Fisher BL. WHO and Fauci Warn COVID-19 Vaccines May not Prevent Infection and Disease Transmission. The Vaccine Reaction Jan. 4, 2020.
30 Johnson & Johnson. Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA for Emergency Use – First Single Shot Vaccine in Fight Against Global Pandemic. Feb. 27, 2021.